S.Res. 251 · 113th Congress
A resolution expressing the sense of the Senate that the United States Preventive Services Task Force should…
Full title
A resolution expressing the sense of the Senate that the United States Preventive Services Task Force should reevaluate its recommendations against prostate-specific antigen-based screening for prostate cancer for men in all age groups in consultation with appropriate specialists.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 113th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
SessionsSponsor4 cosponsors · 1 D, 3 R
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Calls for the U.S. Preventive Services Task Force to: (1) reevaluate its recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups, (2) seriously engage and consult with specialists as it reevaluates its recommendation, and (3) identify areas for additional research and evaluation of methods of treatment…
What it does: CRS summary · Introduced in Senate · Sep 23, 2013
Calls for the U.S. Preventive Services Task Force to: (1) reevaluate its recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups, (2) seriously engage and consult with specialists as it reevaluates its recommendation, and (3) identify areas for additional research and evaluation of methods of treatment of, and screening procedures for, prostate cancer.
Expresses the sense of the Senate that: (1) prostate cancer screening decisions should be made by each individual patient and his physician, taking into account the patient's risk factors and desire for treatment; and (2) steps should be taken to raise awareness of, and increase public knowledge about, prostate cancer, the benefits of early detection, and the appropriateness of screening tests.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: A resolution expressing the sense of the Senate that the United States Preventive Services Task Force should reevaluate its recommendations against prostate-specific antigen-based screening for prostate cancer for men in all age groups in consultation with appropriate specialists.
Latest action (Sep 23, 2013): Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S6684-6685)
Policy area: Health · Origin: Senate · Introduced: Sep 23, 2013
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.